Masitinib clinical program in SCD awarded €9.2M in France

A clinical project designed to test whether masitinib, AB Science’s experimental oral therapy for sickle cell disease (SCD), can resolve complications associated with the inherited disorder has been awarded €9.2 million (about $10 million) in public funding in France. The funding comes as part of a larger investment of €160…

We Need More Awareness of Aplastic Crises

When a sickle cell patient mentions a crisis, most people think of a painful, vaso-occlusive crisis. I can understand why — it’s by far one of the most common complications of sickle cell disease. However, it’s not the only complication that can occur.  One day when I was…

Partners Seek to Educate About Pediatric Blood Transfusions

To inform sickle cell disease (SCD) patients and their caregivers about blood transfusions, which are commonly used to treat the disorder, the Sickle Cell Disease Association of America (SCDAA) is launching a set of educational materials. The pictorial booklet for children, and companion brochure for parents and caregivers,…

Don’t Take Good Health for Granted

Dealing with sickle cell disease is a constant battle. In every moment, I either am fighting my way out of a painful crisis or fighting to stay out of a crisis. There is no rest. I can’t take my foot off the gas. I can’t decide one…

California Earmarks $15M for Expanding Care of Adult SCD Patients

California’s legislature has committed $15 million toward sweeping enhancement of adult sickle cell disease (SCD) care in a state with historically underserved patients. The initiative is intended to improve care largely through creation of a statewide network of regional adult SCD clinics modeled after the newly opened clinic…